NCT02502929

Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians

Lifestyle and Medication Management to Lower Diabetes Risk in Severe Mental Illness

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 182 (actual)
• Sponsor: UConn Health · Academic / Other
• Sex: All
• Age: 35 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The primary aim of the study is to compare the effect of three different interventions on lifestyle risk factors and biological risk factors for type 2 diabetes in depressed Cambodians. The three different interventions are lifestyle, lifestyle plus medication therapy management, and social services.

Detailed description

Cambodian Americans have high risk for major depressive disorder and for type 2 diabetes. Depression is a known risk factor for diabetes. Some antidepressants can also increase risk of diabetes by causing weight gain. DREAM will test the effect of lifestyle and medication therapy management (MTM) compared to social services (control) on diabetes risk among depressed Cambodian Americans. Community health workers (CHWs) will deliver the lifestyle intervention and assist pharmacists with MTM. Lifestyle and biological risk factors for diabetes, such as depressive symptoms, HbA1c and insulin sensitivity, will be measured before and after the interventions.

Conditions

• Diabetes
• Depression

Interventions

Type	Name	Description
BEHAVIORAL	Social Services
BEHAVIORAL	Lifestyle
BEHAVIORAL	Lifestyle Plus Medication Therapy Management

Timeline

• Start date: 2015-11-01
• Primary completion: 2020-09-01
• Completion: 2020-09-01
• First posted: 2015-07-20
• Last updated: 2021-02-05

Locations

3 sites across 1 country: United States